VAN ECK ASSOCIATES CORP - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 153 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2016. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.

Quarter-by-quarter ownership
VAN ECK ASSOCIATES CORP ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q2 2016$573,000
-50.8%
19,237
-51.4%
0.00%
-62.5%
Q1 2016$1,164,000
-56.9%
39,619
+15.0%
0.01%
-61.9%
Q4 2015$2,701,000
+7.3%
34,456
+3.1%
0.02%
+10.5%
Q3 2015$2,518,000
-57.0%
33,409
-33.3%
0.02%
-45.7%
Q2 2015$5,852,000
-49.7%
50,125
+1.8%
0.04%
-47.8%
Q1 2015$11,630,000
+10.0%
49,258
-11.8%
0.07%
+1.5%
Q4 2014$10,575,000
-12.0%
55,875
+11.0%
0.07%
+3.1%
Q3 2014$12,014,00050,3600.06%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q3 2016
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 1,792,114$5,108,0002.15%
Camber Capital Management LP 4,235,000$12,070,0000.52%
Kynam Capital Management, LP 579,915$1,653,0000.42%
GLOBEFLEX CAPITAL L P 419,322$1,195,0000.29%
Eversept Partners, LP 1,435,077$4,089,9690.29%
ARMISTICE CAPITAL, LLC 1,500,000$4,275,0000.08%
RICE HALL JAMES & ASSOCIATES, LLC 506,066$1,442,0000.07%
XTX Topco Ltd 36,130$103,0000.04%
State of Wyoming 20,732$59,0000.04%
Patriot Financial Group Insurance Agency, LLC 55,500$158,0000.03%
View complete list of PUMA BIOTECHNOLOGY INC shareholders